iShares Biotechnology ETF
Limited financial coverage for IBB.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U. S.
- IPO
- 2001
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on IBB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $10.62B
- Div Yield
- 0.16%
- 52W High
- $222.29
- 52W Low
- $159.68
- 50D MA
- $208.88
- 200D MA
- $187.47
- Beta
- 0.70
- RSI (14)
- 37
- Avg Volume
- 1.75M
No earnings-call transcripts are available for IBB yet.
- Free Float
- —
- Shares Outstanding
- 51.65M
- Float Shares
- —
of shares held by institutions
988 13F filers
Congressional trading
Senate and House stock disclosures for IBB, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| David JoyceHouse · OH14 | Sell | Feb 23, 17 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Bank Of America Corp | 6.84M | ▼ 39.44K |
| Citigroup Inc | 4.58M | ▼ 185.66K |
| Morgan Stanley | 4.23M | ▲ 913.38K |
| Goldman Sachs Group Inc | 3.40M | ▲ 2.22M |
| Bnp Paribas Financial Markets | 2.46M | ▲ 241.54K |
| Wells Fargo & Company/Mn | 1.09M | ▲ 57.67K |
| Envestnet Asset Management Inc | 1.09M | ▼ 36.92K |
| Raymond James Financial Inc | 980.69K | ▼ 69.91K |
| Ubs Group AG | 914.56K | ▲ 52.19K |
| Lpl Financial LLC | 910.61K | ▲ 121.22K |
| Commerce Bank | 902.61K | ▼ 6.70K |
| Royal Bank Of Canada | 745.78K | ▼ 3.87K |
Held by 10 ETFs
Biggest fund positions in IBB by dollar value.
Our IBB coverage
Recent articles, reports, and earnings notes.
No research on IBB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBB report →7,518 iShares Biotechnology ETF $IBB Shares Sold by Fifth Third Bancorp
defenseworld.net · Nov 19
Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
fool.com · Nov 15
Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?
fool.com · Nov 15
Two Ways to Play Biotech: FBT's Return Edge vs. IBB's Cost Advantage
fool.com · Nov 14
Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors
fool.com · Nov 7
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
zacks.com · Nov 2
$10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09%
247wallst.com · Oct 31
Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs
247wallst.com · Oct 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.